Adverse Cardiovascular Events after a Venomous Snakebite in Korea

Oh Hyun Kim1, Joon Woo Lee1, Hyung Il Kim1

  • 1Department of Emergency Medicine, Wonju College of Medicine, Yonsei University, Wonju, Korea.

Yonsei Medical Journal
|February 6, 2016
PubMed

Insights

Adverse cardiovascular events (ACVEs) affect 13.8% of venomous snakebite patients in Korea, often involving myocardial injury. Those with ACVEs had more pre-existing heart conditions and bleeding complications.

Area of Science:

  • Cardiology
  • Toxicology
  • Emergency Medicine

Background:

  • Cardiac involvement is an under-recognized complication of venomous snakebites.
  • Limited data exists on adverse cardiovascular events (ACVEs) from snakebites in Korea.

Purpose of the Study:

  • To determine the prevalence of ACVEs in Korean venomous snakebite patients.
  • To compare clinical features between patients with and without ACVEs.

Main Methods:

  • Retrospective review of 65 venomous snakebite cases (May 2011-Oct 2014).
  • ACVEs defined as myocardial injury, shock, ventricular dysrhythmia, or cardiac arrest.
  • Analysis of patient demographics, clinical features, and outcomes.

Main Results:

  • ACVEs occurred in 13.8% of patients (9/65).
  • Myocardial injury (13.8%) and shock (3.1%) were observed; no ventricular dysrhythmia or cardiac arrest.
  • Patients with ACVEs had higher rates of underlying cardiac disease (p=0.017) and bleeding complications (p=0.031).

Conclusions:

  • A significant proportion of venomous snakebite patients experience ACVEs.
  • Underlying cardiac disease and bleeding complications are more common in patients with ACVEs.
Abstract

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
2.4K
Local Anesthetics: Adverse Effects01:12

Local Anesthetics: Adverse Effects

While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
964
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.7K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.9K
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.9K